Celldex Therapeutics Inc CLDX

US Biotechnology

$38.06 ▼ -1.10% ($-0.43)

📅 Earnings This Week

Open $38.50

Prev Close $38.49

Day Range $37.15 – $38.65

52W Range $19.72 – $40.30

Market Cap $2.99B

Beta 0.81

EPS (TTM) $-4.27

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	1986-05-15
Shares Out.	78,490,000
Website	celldex.com/ ↗
Phone	13026587581
Employees	198
Revenue	$15,000
Gross Profit	$15,000
Net Income	-$78.7M
Free Cash Flow	-$226.2M
Total Assets	$511.3M
Total Liabilities	$55.0M
Equity	$456.2M

About Celldex Therapeutics Inc

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Celldex Therapeutics Inc is a publicly traded company under the ticker symbol CLDX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.